The research of Emmanuelle Charpentier and Jennifer Doudna has created explosive advances in biotechnology and biomedicine. Photo: Shutterstock The research of Emmanuelle Charpentier and Jennifer Doudna has created explosive advances in biotechnology and biomedicine. Photo: Shutterstock
The research of Emmanuelle Charpentier and Jennifer Doudna has created explosive advances in biotechnology and biomedicine. Photo: Shutterstock
SCMP Editorial
Opinion

Opinion

Editorial by SCMP Editorial

Patient safety must be paramount in new world of gene editing

  • With the technique called CRISPR discovered by this year’s winners of the Nobel Prize for chemistry, it is now possible to envision treating many incurable diseases and correcting genetic defects before birth. But the public first needs to be reassured that transparent and stringent regulations and monitoring are in place

The research of Emmanuelle Charpentier and Jennifer Doudna has created explosive advances in biotechnology and biomedicine. Photo: Shutterstock The research of Emmanuelle Charpentier and Jennifer Doudna has created explosive advances in biotechnology and biomedicine. Photo: Shutterstock
The research of Emmanuelle Charpentier and Jennifer Doudna has created explosive advances in biotechnology and biomedicine. Photo: Shutterstock
READ FULL ARTICLE